microvision - MVIS
MVIS
Close Chg Chg %
0.65 -0.02 -2.73%
Closed Market
0.64
-0.02 (2.73%)
Volume: 3.69M
Last Updated:
Apr 2, 2026, 4:00 PM EDT
Company Overview: microvision - MVIS
MVIS Key Data
| Open $0.63 | Day Range 0.61 - 0.66 |
| 52 Week Range 0.51 - 1.73 | Market Cap $196.21M |
| Shares Outstanding 306.58M | Public Float 302.64M |
| Beta 1.17 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.35 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 7.62M |
MVIS Performance
| 1 Week | 9.48% | ||
| 1 Month | 10.98% | ||
| 3 Months | -28.63% | ||
| 1 Year | -45.73% | ||
| 5 Years | -95.91% |
MVIS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
About microvision - MVIS
MicroVision, Inc. engages in the development of laser beam scanning technology. The firm integrates micro-electrical mechanical systems, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. It also develops automotive lidar sensors and provides solutions for advanced driver-assistance systems, autonomous vehicles, and non-automotive applications. The company was founded in May 1993 and is headquartered in Redmond, WA.
MVIS At a Glance
MicroVision, Inc.
18390 NE 68th Street
Redmond, Washington 98052
| Phone | 1-425-936-6847 | Revenue | 1.21M | |
| Industry | Semiconductors | Net Income | -94,981,000.00 | |
| Sector | Electronic Technology | Employees | 190 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
MVIS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 187.238 |
| Price to Book Ratio | 4.569 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -2.952 |
| Enterprise Value to Sales | 155.315 |
| Total Debt to Enterprise Value | 0.196 |
MVIS Efficiency
| Revenue/Employee | 6,357.895 |
| Income Per Employee | -499,900.00 |
| Receivables Turnover | 25.702 |
| Total Asset Turnover | 0.011 |
MVIS Liquidity
| Current Ratio | 2.69 |
| Quick Ratio | 2.666 |
| Cash Ratio | 2.499 |
MVIS Profitability
| Gross Margin | -1,435.43 |
| Operating Margin | -5,743.791 |
| Pretax Margin | -7,869.619 |
| Net Margin | -7,862.666 |
| Return on Assets | -84.699 |
| Return on Equity | -182.101 |
| Return on Total Capital | -102.887 |
| Return on Invested Capital | -132.761 |
MVIS Capital Structure
| Total Debt to Total Equity | 66.191 |
| Total Debt to Total Capital | 39.828 |
| Total Debt to Total Assets | 35.656 |
| Long-Term Debt to Equity | 25.313 |
| Long-Term Debt to Total Capital | 15.231 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Microvision - MVIS
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 664.00K | 7.26M | 4.70M | 1.21M | |
Sales Growth
| -73.44% | +993.22% | -35.31% | -74.28% | |
Cost of Goods Sold (COGS) incl D&A
| 2.35M | 10.64M | 14.45M | 18.55M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 2.25M | 7.86M | 6.92M | 5.82M | |
Depreciation
| 2.21M | 5.76M | 4.82M | 4.92M | |
Amortization of Intangibles
| 40.00K | 2.10M | 2.10M | 900.00K | |
COGS Growth
| +60.03% | +353.37% | +35.86% | +28.36% | |
Gross Income
| (1.68M) | (3.38M) | (9.75M) | (17.34M) | |
Gross Income Growth
| -262.67% | -100.77% | -188.84% | -77.77% | |
Gross Profit Margin
| -253.31% | -46.52% | -207.71% | -1,435.43% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 52.21M | 85.53M | 71.44M | 52.05M | |
Research & Development
| 30.41M | 56.71M | 49.02M | 31.72M | |
Other SG&A
| 21.80M | 28.82M | 22.43M | 20.32M | |
SGA Growth
| +16.27% | +63.83% | -16.47% | -27.15% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | 13.05M | 7.97M | - |
EBIT after Unusual Expense
| (53.89M) | (88.91M) | (94.24M) | (77.35M) | |
Non Operating Income/Expense
| 799.00K | 7.21M | 2.29M | 817.00K | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | - | 4.46M | 18.53M | - |
Interest Expense Growth
| - | - | - | +315.77% | - |
Gross Interest Expense
| - | - | 4.46M | 18.53M | - |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (53.09M) | (81.70M) | (96.41M) | (95.06M) | |
Pretax Income Growth
| -22.90% | -53.88% | -18.01% | +1.39% | |
Pretax Margin
| -7,995.63% | -1,125.44% | -2,052.98% | -7,869.62% | |
Income Tax
| - | 1.15M | 507.00K | (84.00K) | |
Income Tax - Current - Domestic
| - | - | - | - | - |
Income Tax - Current - Foreign
| - | 2.06M | 581.00K | 332.00K | |
Income Tax - Deferred - Domestic
| - | - | - | - | - |
Income Tax - Deferred - Foreign
| - | (915.00K) | (74.00K) | (416.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (53.09M) | (82.84M) | (96.92M) | (94.98M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (53.09M) | (82.84M) | (96.92M) | (94.98M) | |
Net Income Growth
| -22.90% | -56.04% | -16.99% | +2.00% | |
Net Margin Growth
| -7,995.63% | -1,141.23% | -2,063.78% | -7,862.67% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (53.09M) | (82.84M) | (96.92M) | (94.98M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (53.09M) | (82.84M) | (96.92M) | (94.98M) | |
EPS (Basic)
| -0.3199 | -0.4532 | -0.4626 | -0.3477 | |
EPS (Basic) Growth
| -18.97% | -41.67% | -2.07% | +24.84% | |
Basic Shares Outstanding
| 165.96M | 182.80M | 209.51M | 273.14M | |
EPS (Diluted)
| -0.3199 | -0.4532 | -0.4626 | -0.3477 | |
EPS (Diluted) Growth
| -18.97% | -41.67% | -2.07% | +24.84% | |
Diluted Shares Outstanding
| 165.96M | 182.80M | 209.51M | 273.14M | |
EBITDA
| (51.64M) | (81.05M) | (74.28M) | (63.56M) | |
EBITDA Growth
| -21.79% | -56.93% | +8.35% | +14.42% | |
EBITDA Margin
| -7,777.71% | -1,116.48% | -1,581.67% | -5,261.67% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 2.50 | |
| Number of Ratings | 2 | Current Quarters Estimate | -0.04 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | -0.165 | |
| Last Quarter’s Earnings | -0.04 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.35 | Next Fiscal Year Estimate | -0.165 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 2 | 2 | 2 | 2 |
| Mean Estimate | -0.04 | -0.04 | -0.17 | -0.17 |
| High Estimates | -0.03 | -0.03 | -0.13 | -0.16 |
| Low Estimate | -0.05 | -0.05 | -0.20 | -0.17 |
| Coefficient of Variance | -35.36 | -35.36 | -30.00 | -4.29 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 1 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Buy |
SEC Filings for Microvision - MVIS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Microvision - MVIS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 10, 2026 | Stephen Hrynewich Interim CFO | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 10, 2026 | Stephen Hrynewich Interim CFO | 162,697 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $0.56 per share | 91,110.32 |
| Mar 10, 2026 | Stephen Hrynewich Interim CFO | 164,256 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jul 29, 2025 | Sumit Sharma CEO; Director | 375,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 29, 2025 | Sumit Sharma CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jul 29, 2025 | Sumit Sharma CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jul 29, 2025 | Sumit Sharma CEO; Director | 1,302,740 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.32 per share | 1,719,616.80 |
| Jul 29, 2025 | Sumit Sharma CEO; Director | 1,644,671 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jul 29, 2025 | Sumit Sharma CEO; Director | 1,273,421 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 10, 2025 | Jeffrey A Herbst Director | 164,706 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 10, 2025 | Peter Schabert Director | 87,642 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 10, 2025 | Peter Schabert Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 10, 2025 | Jada Smith Director | 60,337 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 10, 2025 | Jada Smith Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 10, 2025 | Jada Smith Director | 87,642 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 10, 2025 | Peter Schabert Director | 80,450 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 10, 2025 | Jeffrey A Herbst Director | 87,642 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 10, 2025 | Jeffrey A Herbst Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 4, 2025 | Glen W. DeVos SVP, Chief Technology Officer | 1,300,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |